Antineoplastic activity of isoliquiritigenin, a chalcone compound, in androgen‐independent human prostate cancer cells linked to G2/M cell cycle arrest and cell apoptosis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  European Journal of Pharmacology

• Publication date

  2018-02-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejphar.2017.12.053PMID 29277717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Resveratrol induces cell cycle arrest and apoptosis with docetaxel in prostate cancer cells via a p53/ p21WAF1/CIP1 and p27KIP1 pathway

  2017cited by this paper
• Isoliquiritigenin induces apoptosis and autophagy and inhibits endometrial cancer growth in mice

  2016cited by this paper
• 14-3-3σ Gene Loss Leads to Activation of the Epithelial to Mesenchymal Transition Due to the Stabilization of c-Jun Protein*

  2016cited by this paper
• Cancer statistics, 2016

  2016cited by this paper
• Isoliquiritigenin as a cause of DNA damage and inhibitor of ataxia‐telangiectasia mutated expression leading to G2/M phase arrest and apoptosis in oral squamous cell carcinoma

  2016cited by this paper
• Natural Product Modulators to Overcome Multidrug Resistance In Cancer

  2015influential reference
• Expression of CDK1Tyr15, pCDK1Thr161, Cyclin B1 (Total) and pCyclin B1Ser126 in Vulvar Squamous Cell Carcinoma and Their Relations with Clinicopatological Features and Prognosis

  2015cited by this paper
• Isoliquiritigenin attenuates oxidative hepatic damage induced by carbon tetrachloride with or without buthionine sulfoximine.

  2015cited by this paper
• Targeting heat-shock protein 90 with ganetespib for molecularly targeted therapy of gastric cancer

  2015cited by this paper
• The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics.

  2015cited by this paper
• Downregulation of COX-2 and CYP 4A signaling by isoliquiritigenin inhibits human breast cancer metastasis through preventing anoikis resistance, migration and invasion.

  2014cited by this paper
• Therapeutic ROS targeting of GADD45γ in the induction of G2/M arrest in primary human colorectal cancer cell lines by cucurbitacin E

  2014influential reference
• Dietary Compound Isoliquiritigenin Inhibits Breast Cancer Neoangiogenesis via VEGF/VEGFR-2 Signaling Pathway

  2013cited by this paper
• Isoliquiritigenin inhibits proliferation and induces apoptosis of U87 human glioma cells in vitro.

  2013cited by this paper
• Gadd45 in stress signaling, cell cycle control, and apoptosis.

  2013cited by this paper
• Natural products as sources of new drugs over the 30 years from 1981 to 2010.

  2012cited by this paper
• Isoliquiritigenin inhibits the growth of multiple myeloma via blocking IL-6 signaling

  2012cited by this paper
• Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells.

  2012cited by this paper
• Skp2: a novel potential therapeutic target for prostate cancer.

  2012cited by this paper
• Therapeutic Options for Advanced Prostate Cancer: 2011 Update

  2012cited by this paper
• Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models

  2011cited by this paper
• Bcl-2 proteins and mitochondria--specificity in membrane targeting for death.

  2011cited by this paper
• Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence

  2010cited by this paper
• Licorice isoliquiritigenin dampens angiogenic activity via inhibition of MAPK-responsive signaling pathways leading to induction of matrix metalloproteinases.

  2010cited by this paper
• Primary research on chinese medicine treatment of androgen-independent prostate cancer

  2009cited by this paper
• Bim-targeted cancer therapy: A link between drug action and underlying molecular changes

  2009cited by this paper
• Induction of Cell Cycle Arrest in Prostate Cancer Cells by the Dietary Compound Isoliquiritigenin

  2009cited by this paper
• Isoliquiritigenin induces monocytic differentiation of HL-60 cells.

  2009cited by this paper
• Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer.

  2009cited by this paper
• Shallot and licorice constituent isoliquiritigenin arrests cell cycle progression and induces apoptosis through the induction of ATM/p53 and initiation of the mitochondrial system in human cervical carcinoma HeLa cells.

  2009cited by this paper
• Dietary administration of the licorice flavonoid isoliquiritigenin deters the growth of MCF‐7 cells overexpressing aromatase

  2009cited by this paper
• Isoliquiritigenin induces G2 and M phase arrest by inducing DNA damage and by inhibiting the metaphase/anaphase transition.

  2009cited by this paper
• Isoliquiritigenin inhibits migration and invasion of prostate cancer cells: possible mediation by decreased JNK/AP-1 signaling.

  2009cited by this paper
• Focus on acetylation: the role of histone deacetylase inhibitors in cancer therapy and beyond

  2007cited by this paper
• The Complex Role of AR Signaling After Cytotoxic Insult: Implications for Cell Cycle Based Chemotherapeutics

  2007cited by this paper
• Histone deacetylase inhibitors: signalling towards p21cip1/waf1.

  2007cited by this paper
• The radiation response of hormone-resistant prostate cancer induced by long-term hormone therapy.

  2007cited by this paper
• Isoliquiritigenin inhibits IκB kinase activity and ROS generation to block TNF-α induced expression of cell adhesion molecules on human endothelial cells

  2007cited by this paper
• Isoliquiritigenin inhibits IkappaB kinase activity and ROS generation to block TNF-alpha induced expression of cell adhesion molecules on human endothelial cells.

  2007cited by this paper
• 14-3-3σ, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma

  2006cited by this paper
• 14-3-3sigma, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma.

  2006cited by this paper
• Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function.

  2005cited by this paper
• Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells.

  2005cited by this paper
• Isoliquiritigenin induces apoptosis and cell cycle arrest through p53-dependent pathway in Hep G2 cells.

  2005cited by this paper
• Chemotherapy for hormone-refractory prostate cancer: now it's a question of "when?".

  2005cited by this paper
• Prostate cancer is characterized by epigenetic silencing of 14-3-3σ expression

  2004cited by this paper
• Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression.

  2004cited by this paper
• MDM2 Is a Negative Regulator of p21WAF1/CIP1, Independent of p53*

  2004cited by this paper
• Bim is a suppressor of Myc-induced mouse B cell leukemia.

  2004cited by this paper
• Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer.

  2004cited by this paper
• Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.

  2004cited by this paper
• Molecular determinants of resistance to antiandrogen therapy

  2004cited by this paper
• ISOLIQUIRITIGENIN INHIBITS THE PROLIFERATION AND INDUCES THE APOPTOSIS OF HUMAN NON‐SMALL CELL LUNG CANCER A549 CELLS

  2004cited by this paper
• Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells.

  2004cited by this paper
• Androgen receptor in prostate cancer.

  2004cited by this paper
• Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development

  2004cited by this paper
• Cancer chemoprevention with dietary phytochemicals

  2003cited by this paper
• Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.

  2002cited by this paper
• The Current State of Hormonal Therapy for Prostate Cancer

  2002cited by this paper
• Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.

  2002cited by this paper
• Elevated Skp 2 Protein Expression in Human Prostate Cancer : Association with Loss of the Cyclin-dependent Kinase Inhibitor p 27 and PTEN and with Reduced Recurrence-free Survival 1

  2002cited by this paper
• Estrogen-like activity of glabrene and other constituents isolated from licorice root.

  2001cited by this paper
• Regulation of the G2/M transition by p53

  2001cited by this paper
• 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage.

  1999cited by this paper
• 14-3-3σ is required to prevent mitotic catastrophe after DNA damage

  1999cited by this paper
• Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.

  1941cited by this paper
• Cited Articles Citing Articles E-mail Alerts Curcumin, a Dietary Component, Has Anticancer, Chemosensitization, and Radiosensitization Effects by Down-regulating the Mdm2 Oncogene through the Pi3k/mtor/ets2 Pathway

  year unknowncited by this paper

• The Role of Ayurveda in Prostate Cancer Management

  2025cites this paper
• Isoliquiritigenin Suppresses Fatty Acid Synthesis and Cancer Cell Migration in Anaplastic Thyroid Carcinoma through AMPK/SREBF1 Pathway.

  2025cites this paper
• The Role of Natural Chalcones and Their Derivatives in Targeting Prostate Cancer: Recent Updates

  2025cites this paper
• Unveiling the Therapeutic Potential of Isoliquiritigenin in Prostate Cancer: Insights from a Systematic Review and Meta-Analysis

  2025cites this paper
• Importance of Synthesized Chalcone‐Functionality for Derivatization and Their Biological Activity

  2025cites this paper
• Surveying the Therapeutic Potentials of Isoliquiritigenin (ISL): A Comprehensive Review

  2025cites this paper
• Saikosaponin-b2 Regulates the Proliferation and Apoptosis of Liver Cancer Cells by Targeting the MACC1/c-Met/Akt Signalling Pathway

  2024cites this paper
• Simultaneous Enrichment and Purification of Licorice Chalcone A and Isoliquiritigenin in Licorice Using a Mixed-Mode Monolith

  2024cites this paper
• 2,4,6-Trimethoxy chalcone derivatives: an integrated study for redesigning novel chemical entities as anticancer agents through QSAR, molecular docking, ADMET prediction, and computational simulation

  2024cites this paper
• Recent advances in dietary androgen receptor inhibitors

  2024cites this paper
• Regulatory mechanism of the Glabrene against non‐small cell lung cancer by suppressing FGFR3

  2024cites this paper
• Unveiling the Essence of Isoliquiritigenin: Exploring Its Chemistry, Pharmacokinetics, and Pharmacological Potential

  2024cites this paper
• Investigation of Anti-Cancer Activity of Newly Synthesized 2,4-pentadien-1-one Derivative Containing Benzofuran in Human Lung and Colon Cancer Cells

  2023cites this paper
• Isoliquiritigenin Inhibits the Growth of Colorectal Cancer Cells through the ESR2/PI3K/AKT Signalling Pathway

  2023cites this paper
• 2,4'-dihydroxy-6'-methoxy-3',5'-dimethylchalcone from Cleistocalyx nervosum var. paniala seeds attenuated the early stage of diethylnitrosamine and 1,2-dimethylhydrazine-induced colorectal carcinogenesis.

  2023cites this paper
• Anticancer Potential of Natural Chalcones: In Vitro and In Vivo Evidence

  2023cites this paper
• Recent Progresses in Chalcone Derivatives as Potential Anticancer Agents.

  2023cites this paper
• Structural, spectroscopic and quantum chemical analysis of an exocyclic extended double-bonded chalcone single crystal, with pharmaceutical scanning for breast cancer using MCF-7 cell line and EGFR domain target

  2022cites this paper
• Crystal structure, Hirshfeld surfaces and energy framework studies of a biologically active compound (3E)-3-(2,3,4-trimethoxyphenyl) methylidene)-2,3-dihydro-4H-1-benzopyran-4-one

  2022cites this paper
• Synthesis and Biological Activities of New Hybrid Chalcones with Benzoic Acid Ring

  2022cites this paper
• Chemotherapeutics activities of dietary phytoestrogens against prostate cancer: From observational to clinical studies.

  2022cites this paper
• Synthesis and Chemical Exploration of an Organic Exocyclic Chalcone Derivative for Its Therapeutic Proficiency against Breast Cancer

  2022cites this paper
• Hybrid Membrane-Derived Nanoparticles for Isoliquiritin Enhanced Glioma Therapy

  2022cites this paper
• Oncopreventive and Oncotherapeutic Potential of Licorice Chalcone Compounds: Molecular Insights.

  2022cites this paper
• Anti-inflammation of isoliquiritigenin via the inhibition of NF-κB and MAPK in LPS-stimulated MAC-T cells

  2022cites this paper
• Pharmacological Effects and Underlying Mechanisms of Licorice-Derived Flavonoids

  2022cites this paper
• STRUCTURAL EXAMINATION, THEORETICAL CALCULATIONS, AND PHARMACEUTICAL SCANNING OF A NEW TETRALONE BASED CHALCONE DERIVATIVE

  2021cites this paper
• Perspectives on the Role of Isoliquiritigenin in Cancer

  2021cites this paper
• tRNALys-Derived Fragment Alleviates Cisplatin-Induced Apoptosis in Prostate Cancer Cells

  2021influential citation
• Purification of Gekko Small Peptide Fraction and Its Effect of Inducing Apoptosis of EC 9706 Esophageal Cancer Cells by Inhibiting PI3K/Akt/GLUT1 Signaling Pathway

  2021cites this paper
• Molecular Mechanisms of Antiproliferative Effects of Natural Chalcones

  2021cites this paper
• Chalcone Derivatives: Role in Anticancer Therapy

  2021cites this paper
• New insights into binding of natural chalcones to Bcl-2, Bcl-xL and Mcl-1 anti-apoptotic proteins

  2021cites this paper
• Chalcones: Synthetic Chemistry Follows Where Nature Leads

  2021cites this paper
• Naturally occurring heterocyclic anticancer compounds

  2021cites this paper
• From natural products to HDAC inhibitors: An overview of drug discovery and design strategy.

  2021cites this paper
• Chalcones against the hallmarks of cancer: a mini-review

  2021cites this paper
• DDDT_A_270124 4363..4376

  2020cites this paper
• ISL Induces Apoptosis and Autophagy in Hepatocellular Carcinoma via Downregulation of PI3K/AKT/mTOR Pathway in vivo and in vitro

  2020cites this paper
• Characterization and Cytotoxic Activity of Dalbergia latifolia Wood Extract

  2020cites this paper
• Isoliquiritigenin inhibits the survival of diffuse large B-cell lymphoma cells by regulating Akt/mTOR signaling pathway

  2020cites this paper
• Discovery of novel isoliquiritigenin analogue ISL-17 as a potential anti-gastric cancer agent

  2020cites this paper
• Anticancer activities of phytoconstituents and their liposomal targeting strategies against tumor cells and the microenvironment.

  2020cites this paper
• Natural Chalcones in Chinese Materia Medica: Licorice

  2020cites this paper
• Molecular mechanisms underlying the anticancer activities of licorice flavonoids.

  2020cites this paper
• New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.

  2020cites this paper
• Isoliquiritigenin Suppressed Esophageal Squamous Carcinoma Growth by Blocking EGFR Activation and Inducing Cell Cycle Arrest

  2020cites this paper
• Feeding preference of Altica deserticola for leaves of Glycyrrhiza glabra and G. uralensis and its mechanism

  2020cites this paper
• Glycyrrhiza glabra-Enhanced Extract and Adriamycin Antiproliferative Effect on PC-3 Prostate Cancer Cells

  2020cites this paper
• Anti-tumor effects of isoliquiritigenin in Bcl-2/Bax and PCNA expression of T24 human bladder cancer cells

  2020cites this paper
• Role of Phytochemicals in Modulating Signaling Cascades in Cancer Cells

  2020cites this paper
• Antimutagenic components in Spatholobus suberectus Dunn against N-methyl-N-nitrosourea

  2019cites this paper
• Isoliquiritigenin, an Orally Available Natural FLT3 Inhibitor from Licorice, Exhibits Selective Anti–Acute Myeloid Leukemia Efficacy In Vitro and In Vivo

  2019cites this paper
• Isoliquiritigenin, an orally available natural FLT3 inhibitor from licorice, exhibits selective anti-AML efficacy in vitro and in vivo

  2019cites this paper
• The dietary flavonoid isoliquiritigenin is a potent cytotoxin for human neuroblastoma cells

  2019cites this paper
• Isoliquiritigenin Induces Mitochondrial Dysfunction and Apoptosis by Inhibiting mitoNEET in a Reactive Oxygen Species-Dependent Manner in A375 Human Melanoma Cells

  2019cites this paper
• Isoliquiritigenin inhibits the proliferation, migration and metastasis of Hep3B cells via suppressing cyclin D1 and PI3K/AKT pathway

  2019cites this paper
• Isoliquiritigenin suppresses human melanoma growth by targeting miR-301b/LRIG1 signaling

  2018cites this paper
• Isoliquiritigenin (ISL) and its formulations: potential antitumor agents.

  2018cites this paper
• Isoliquiritigenin alleviated the Ang II-induced hypertensive renal injury through suppressing inflammation cytokines and oxidative stress-induced apoptosis via Nrf2 and NF-κB pathways.

  2018cites this paper
• β-Bourbonene attenuates proliferation and induces apoptosis of prostate cancer cells

  2018cites this paper
• New chalcone derivative exhibits antiproliferative potential by inducing G2/M cell cycle arrest, mitochondrial-mediated apoptosis and modulation of MAPK signalling pathway.

  2018cites this paper